Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Ross-MacDonald

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Expert Review of Molecular Diagnostics|December 26, 2006
Drug discovery without a molecular target: the road less traveledPetra Ross-Macdonald
Pharmacogenomics|July 12, 2005
Forward in reverse: how reverse genetics complements chemical geneticsPetra Ross-Macdonald
Pharmacology & Therapeutics|July 31, 2003
Model systems in drug discovery: chemical genetics meets genomicsPamela M Carroll, Brian Dougherty, Petra Ross-Macdonald, et al.
Plos One|April 1, 2015
Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytesJacques Friborg, Petra Ross-Macdonald, Jian Cao, et al.
Bioinformatics (Oxford, England)|September 12, 2007
Construction of a reference gene association network from multiple profiling data: application to data analysisDuygu Ucar, Isaac Neuhaus, Petra Ross-MacDonald, et al.
Science Advances|September 16, 2022
Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapyJohn-William Sidhom, Giacomo Oliveira, Petra Ross-MacDonald, et al.
Journal for Immunotherapy of Cancer|March 4, 2021
Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCCPetra Ross-Macdonald, Alice M Walsh, Scott D Chasalow, et al.
Journal for Immunotherapy of Cancer|February 8, 2022
Soluble PD-L1 as an early marker of progressive disease on nivolumabKathleen M Mahoney, Petra Ross-Macdonald, Long Yuan, et al.
Molecular Cancer Therapeutics|August 9, 2015
Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene ExpressionRyan Lenhart, Stefan Kirov, Heshani Desilva, et al.
Molecular Cancer Therapeutics|November 13, 2008
Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitorsPetra Ross-Macdonald, Heshani de Silva, Qi Guo, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Review of Molecular Diagnostics|December 26, 2006
Drug discovery without a molecular target: the road less traveledPetra Ross-Macdonald
Pharmacogenomics|July 12, 2005
Forward in reverse: how reverse genetics complements chemical geneticsPetra Ross-Macdonald
Pharmacology & Therapeutics|July 31, 2003
Model systems in drug discovery: chemical genetics meets genomicsPamela M Carroll, Brian Dougherty, Petra Ross-Macdonald, et al.
Plos One|April 1, 2015
Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytesJacques Friborg, Petra Ross-Macdonald, Jian Cao, et al.
Bioinformatics (Oxford, England)|September 12, 2007
Construction of a reference gene association network from multiple profiling data: application to data analysisDuygu Ucar, Isaac Neuhaus, Petra Ross-MacDonald, et al.
Science Advances|September 16, 2022
Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapyJohn-William Sidhom, Giacomo Oliveira, Petra Ross-MacDonald, et al.
Journal for Immunotherapy of Cancer|March 4, 2021
Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCCPetra Ross-Macdonald, Alice M Walsh, Scott D Chasalow, et al.
Journal for Immunotherapy of Cancer|February 8, 2022
Soluble PD-L1 as an early marker of progressive disease on nivolumabKathleen M Mahoney, Petra Ross-Macdonald, Long Yuan, et al.
Molecular Cancer Therapeutics|August 9, 2015
Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene ExpressionRyan Lenhart, Stefan Kirov, Heshani Desilva, et al.
Molecular Cancer Therapeutics|November 13, 2008
Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitorsPetra Ross-Macdonald, Heshani de Silva, Qi Guo, et al.
Pageof 3